Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma

Recruiting now · Not applicable

Conditions studied: Pheochromocytoma/Paraganglioma (PPGL)

In brief

The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).

Key facts

Study ID

NCT07288931

Run by

Peking Union Medical College Hospital

People needed

40

Starts

2024-08-06

Expected to finish

2026-03-01

Last updated by the study team

2025-12-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 to 80 years.
• Suspected or confirmed PPGL patients.

You may not qualify if…

• Combined with other types of tumors.
• Severe liver or renal dysfunction (ALT/AST≥5 ULN, GFR<30ml/min).
• Pregnant or breast-feeding women.
• Inability to perform PET/CT scans.

Where it is running

• Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.